Humana's value-based care agreements yield 13% increase in colon cancer screenings: 7 things to know

Touting 900-plus relationships with value-based provider organizations and 51,500 physicians in value-based agreements, Humana released an internal study showing the results of its value-based agreements.

Here are seven things to know:

1. Compared to traditional fee-for-service Medicare, total healthcare costs were 15 percent lower under Humana value-based care plans.

2. Humana's value-based agreements yielded 4 percent lower total healthcare costs than Humana standard Medicare Advantage settings.

3. Humana found several superior outcomes under its value-based agreements, including
•    7 percent fewer emergency department visits
•    6 percent fewer hospital inpatient admissions
•    7 percent increase in controlling blood sugars
•    7 percent increase in diabetes care/controlling blood sugar
•    2 percent increase in medication adherence

4. The company's value-based agreements led to a 13 percent increase in colorectal cancer screenings and 8 percent increase in breast cancer screenings.

5. The study found physicians in value-based agreements from 2014 to 2016 had a Healthcare Effectiveness Data and Information Set score of 4.36.

6. Physicians in a FFS agreement had a HEDIS score of 3.44 at the end of 2016.

7. Physicians that transitioned from a FFS agreement to a value-based care agreement in 2015 yielded an overall HEDIS score of 4.31 at the end of 2016.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast